June 24, 2021: Earlier today, RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation, broke ground on the state’s first freestanding cancer hospital. At the ceremony, it was also announced that the 510,000-square-foot structure will be named the Jack and Sheryl Morris Cancer Center in recognition of the philanthropic leadership of Jack Morris, who has been a longtime supporter and pillar in New Brunswick development, and his wife, Sheryl. The 12-story facility, to be located on Somerset Street, will house inpatient, outpatient and ancillary services, as well as state-of-the-art laboratories where research faculty can provide hands-on educational opportunities for... Read More
June 18, 2021: Amanda Parkes, MD, a medical oncologist specializing in sarcoma and breast cancer at the University of Wisconsin Carbone Cancer Center, has been named co-chair of the Big Ten Cancer Research Consortium’s Adolescent and Young Adult (AYA) Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group. Dr. Parkes, an assistant professor at University of Wisconsin School of Medicine and Public Health, has been a member of the consortium’s Breast Cancer Clinical Trial Working Group and the Sarcoma Clinical Trial Working Group since 2018. She has also participated as an investigator in several Big Ten CRC breast cancer trials and is leading the new breast... Read More
June 11, 2021: Big Ten Cancer Research Consortium investigators presented six abstracts during the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting held virtually June 4-8. Read More
June 2, 2021: This month, the Big Ten Cancer Research Consortium highlights our member, Penn State Cancer Institute. Get to know more about Penn State Cancer Institute investigator Monika Joshi, MD, MRCP.
Monika Joshi, MD, MRCP
Associate Professor, Department of Medicine, Division of Hematology and Oncology Penn State Cancer Institute, Next Generation Therapies
Educational Background Medical degree/MBBS: Manipal Academy of Higher Education Residency: UPMC Pinnacle, Harrisburg, Pa. Fellowship: Penn State Health Milton S. Hershey Medical Center, Hershey, Pa. Specialist Registrar (Fellow): University...
Read More
May 23, 2021: In this edition of Across the Consortium, we highlight researchers who are exploring cellular function as it relates to cancer, including drug molecules and genetic mutation, and those who are looking to the physical traits of the mantis shrimp to enhance removal of cancer cells during surgery. We also recognize investigators that are taking on new leadership roles and starting new programs to provide more comprehensive care at their cancer center, and highlight an oncology nurse as part of Nursing Oncology Month. Discover what is happening across the Big Ten CRC. Read More
May 5, 2021: This month, the Big Ten Cancer Research Consortium highlights our member, the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). Get to know UMGCCC investigator Yixing Jiang, MD, PhD, and learn about a novel approach currently being tested to deliver treatment across the blood-brain barrier in high-grade gliomas.
Yixing Jiang, MD, PhD
Associate Professor of Medicine; Director, GI Medical Oncology University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
Educational Background MD, Shanghai Medical College of Fudan University PhD, Mount...
Read More
April 29, 2021: Researchers across the Big Ten Cancer Research Consortium are shedding light on new discoveries that could improve the health and lives of many in years to come through a host of precision medicine strategies. From boosting mitochondrial function in a subpopulation of T cells to analyzing vast amounts of data in populations, and synthesizing a rare compound found in a Native America shrub to combat a protein found in many cancers, these researchers are covering all the bases to make a difference. Learn about them and other investigators on the move in this issue of Across the Consortium. Read More
April 5, 2021 Investigator Spotlight: Channabasavaiah B. Gurumurthy BVSC (DVM), MVSC, PhD, MBA, University of Nebraska Medical Center Research Interests: I am a professor of Pharmacology and Experimental Neuroscience and director of the Mouse Genome Engineering Core Facility. My research interest is in enhancing technologies for biomedical research. I develop genome-editing technologies and custom mouse models useful to research ranging from cancer to neuroscience to COVID-19 research. I am fortunate to work in the interface of two Nobel awarded technologies:... Read More
March 23, 2021: Analysis from the Big Ten Cancer Research Consortium metastatic urothelial carcinoma (mUC) phase 1b study, BTCRC-GU16-051, shows the combination of eribulin mesylate and avelumab is safe and demonstrates efficacy signals that warrant further evaluation in adults with cisplatin-ineligible mUC. In their report, published in European Urology Focus, researchers also noted that the treatment combination was better tolerated and efficacious at lower doses of eribulin mesylate. Monika Joshi, MD, MRCP (pictured left), of Penn State Cancer Institute, led the study in collaboration with Yousef... Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube